Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study
Crossref DOI link: https://doi.org/10.1007/s40268-017-0209-5
Published Online: 2017-09-11
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Buti, Sebastiano
Donini, Maddalena
Bersanelli, Melissa
Gattara, Alessia
Leonardi, Francesco
Passalacqua, Rodolfo
License valid from 2017-09-11